Literature DB >> 26141267

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

E L Hanson1, R E Hershberger.   

Abstract

Idiopathic dilated cardiomyopathy (IDC), a treatable condition characterized by left ventricular dilatation and systolic dysfunction of unknown cause, has only recently been recognized to have genetic etiologies. Although familial dilated cardiomyopathy (FDC) was thought to be infrequent, it is now believed that 30-50% of cases of IDC may be familial. Echocardiographic and electrocardiographic (ECG) screening of first-degree relatives of individuals with IDC and FDC is indicated because detection and treatment are possible prior to the onset of advanced, symptomatic disease. However, such screening often creates uncertainty and anxiety surrounding the significance of the results. Furthermore, FDC demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making genetic counseling complex. The provision of genetic counseling for IDC and FDC will require collaboration between cardiologists and genetics professionals, and may also improve the recognition of FDC, the availability of support services, and overall outcomes for patients and families.

Entities:  

Year:  2001        PMID: 26141267     DOI: 10.1023/A:1016641504606

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  72 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

2.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.

Authors:  V V Michels; P P Moll; F A Miller; A J Tajik; J S Chu; D J Driscoll; J C Burnett; R J Rodeheffer; J H Chesebro; H D Tazelaar
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

3.  Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy.

Authors:  E Takai; H Akita; N Shiga; K Kanazawa; S Yamada; M Terashima; Y Matsuda; C Iwai; K Kawai; Y Yokota; M Yokoyama
Journal:  Am J Med Genet       Date:  1999-10-08

4.  Familial dilated cardiomyopathy: echocardiographic diagnostic criteria for classification of family members as affected.

Authors:  R E Hershberger; H Ni; K A Crispell
Journal:  J Card Fail       Date:  1999-09       Impact factor: 5.712

5.  Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice.

Authors:  K A Crispell; A Wray; H Ni; D J Nauman; R E Hershberger
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

6.  Peripartum maternal cardiomyopathy with idiopathic cardiomyopathy in the offspring. A case report.

Authors:  I I Ferguson JE; K S Harney; J A Bachicha
Journal:  J Reprod Med       Date:  1986-12       Impact factor: 0.142

7.  Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.

Authors:  M Krajinovic; B Pinamonti; G Sinagra; M Vatta; G M Severini; J Milasin; A Falaschi; F Camerini; M Giacca; L Mestroni
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

8.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

9.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 10.  Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes?

Authors:  C J Hutchison; M Alvarez-Reyes; O A Vaughan
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

View more
  5 in total

Review 1.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Ray E Hershberger; Jill D Siegfried
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

2.  Return of genetic results in the familial dilated cardiomyopathy research project.

Authors:  Jill D Siegfried; Ana Morales; Jessica D Kushner; Emily Burkett; Jason Cowan; Ana Clara Mauro; Gordon S Huggins; Duanxiang Li; Nadine Norton; Ray E Hershberger
Journal:  J Genet Couns       Date:  2012-08-11       Impact factor: 2.537

Review 3.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Ray E Hershberger; Jason Cowan; Ana Morales; Jill D Siegfried
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

4.  Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.

Authors:  Ray E Hershberger; Ana Morales; Jill D Siegfried
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822

5.  Lamin A/C truncation in dilated cardiomyopathy with conduction disease.

Authors:  Heather M MacLeod; Mary R Culley; Jill M Huber; Elizabeth M McNally
Journal:  BMC Med Genet       Date:  2003-07-10       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.